Mai Capital Management Abeona Therapeutics Inc. Transaction History
Mai Capital Management
- $13 Billion
- Q1 2025
A detailed history of Mai Capital Management transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Mai Capital Management holds 1,620 shares of ABEO stock, worth $10,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,620Holding current value
$10,400% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABEO
# of Institutions
77Shares Held
27.8MCall Options Held
556KPut Options Held
34.9K-
Suvretta Capital Management, LLC New York, NY3.69MShares$23.7 Million0.77% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.51MShares$22.5 Million0.75% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.69MShares$17.3 Million0.02% of portfolio
-
Western Standard LLC Los Angeles, CA2.28MShares$14.6 Million6.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.02MShares$13 Million0.0% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $38.2M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...